Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,175 | 4,046 | 3,282 | 8,084 | 2,729 |
| Operating Income | -4,175 | -4,046 | -3,282 | -8,084 | -2,729 |
| Other Income | 23 | 21 | 24 | 44 | 60 |
| Pre-tax Income | -4,152 | -4,025 | -3,258 | -8,040 | -2,669 |
| Net Income Continuous | -4,152 | -4,025 | -3,258 | -8,040 | -2,669 |
| Net Income | $-4,152 | $-4,025 | $-3,258 | $-8,040 | $-2,669 |
| EPS Basic Total Ops | -0.30 | -0.30 | -0.25 | -0.62 | -0.20 |
| EPS Basic Continuous Ops | -0.30 | -0.30 | -0.25 | -0.62 | -0.20 |
| EPS Diluted Total Ops | -0.30 | -0.30 | -0.25 | -0.62 | -0.20 |
| EPS Diluted Continuous Ops | -0.30 | -0.30 | -0.25 | -0.62 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.30 | -0.25 | -0.61 | -0.20 |
| EBITDA(a) | $-4,175 | $-4,045 | $-3,281 | $-8,083 | $-2,728 |